HK1154589A1 - 螺酮縮醇衍生物的結晶及其製備方法 - Google Patents

螺酮縮醇衍生物的結晶及其製備方法

Info

Publication number
HK1154589A1
HK1154589A1 HK11108698.5A HK11108698A HK1154589A1 HK 1154589 A1 HK1154589 A1 HK 1154589A1 HK 11108698 A HK11108698 A HK 11108698A HK 1154589 A1 HK1154589 A1 HK 1154589A1
Authority
HK
Hong Kong
Prior art keywords
crystal
production
spiroketal derivative
spiroketal
derivative
Prior art date
Application number
HK11108698.5A
Other languages
English (en)
Inventor
Masatoshi Murakata
Takuma Ikeda
Nobuaki Kimura
Akira Kawase
Masahiro Nagase
Keisuke Yamamoto
Noriyuki Takata
Shinichi Yoshizaki
Koji Takano
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41434188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1154589(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1154589A1 publication Critical patent/HK1154589A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04Carbocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK11108698.5A 2008-06-20 2011-08-17 螺酮縮醇衍生物的結晶及其製備方法 HK1154589A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008162073 2008-06-20
PCT/JP2009/061226 WO2009154276A1 (ja) 2008-06-20 2009-06-19 スピロケタール誘導体の結晶およびその製造方法

Publications (1)

Publication Number Publication Date
HK1154589A1 true HK1154589A1 (zh) 2012-04-27

Family

ID=41434188

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11108698.5A HK1154589A1 (zh) 2008-06-20 2011-08-17 螺酮縮醇衍生物的結晶及其製備方法

Country Status (25)

Country Link
US (2) US8569520B2 (zh)
EP (3) EP3170834B8 (zh)
JP (2) JP4823385B2 (zh)
KR (1) KR101856784B1 (zh)
CN (1) CN102046645B (zh)
AR (1) AR072211A1 (zh)
AU (1) AU2009261129A1 (zh)
CA (1) CA2727923A1 (zh)
CL (1) CL2010001485A1 (zh)
CO (1) CO6351798A2 (zh)
CR (1) CR20110033A (zh)
EC (1) ECSP11010773A (zh)
ES (1) ES2907611T3 (zh)
HK (1) HK1154589A1 (zh)
IL (1) IL210098A0 (zh)
MA (1) MA32530B1 (zh)
MX (1) MX2010014023A (zh)
NZ (1) NZ589961A (zh)
PE (1) PE20110115A1 (zh)
PL (1) PL3170834T3 (zh)
RU (1) RU2011101972A (zh)
SG (1) SG193795A1 (zh)
TW (1) TW201011043A (zh)
WO (1) WO2009154276A1 (zh)
ZA (1) ZA201100016B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011074675A1 (ja) * 2009-12-18 2011-06-23 中外製薬株式会社 スピロケタール誘導体の製造方法
WO2012115249A1 (ja) * 2011-02-25 2012-08-30 中外製薬株式会社 スピロケタール誘導体の結晶
MX355016B (es) * 2011-10-06 2018-04-02 Bayer Ip Gmbh Heterociclilpiri(mi)dinilpirazoles como fungicidas.
RU2700164C2 (ru) * 2013-12-27 2019-09-13 Чугаи Сейяку Кабусики Кайся Твердые препараты, содержащие тофоглифлозин, и способ их получения
CN106188190B (zh) * 2016-07-28 2020-08-25 迪嘉药业集团有限公司 一种托格列净一水合物的制备方法
CN109843279A (zh) 2016-10-19 2019-06-04 勃林格殷格翰国际有限公司 包含ssao/vap-1抑制剂和sglt2抑制剂的药物组合、其用途
CN108640958B (zh) * 2017-05-05 2021-03-30 镇江圣安医药有限公司 异苯并呋喃衍生物、其药物组合物和制剂以及用途
EP3781166A1 (en) 2018-04-17 2021-02-24 Boehringer Ingelheim International GmbH Pharmaceutical composition, methods for treating and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
HU196775B (en) 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
PT98344B (pt) 1991-07-17 1999-04-30 Lneti Lab Nac De Eng Tec Ind D Processo para a obtencao de espirocetais labdanicos do tipo ambar cinzento
GB9426103D0 (en) 1994-12-23 1995-02-22 Merck Sharp & Dohme Therapeutic agents
JP2000044534A (ja) * 1998-07-28 2000-02-15 Mitsui Chemicals Inc N保護基アミノ酸の製造法
US6946559B2 (en) 2000-02-02 2005-09-20 Banyu Pharmaceutical Co., Ltd. Method of converting functional group through halogen-metal exchange reaction
JP3849024B2 (ja) 2003-03-26 2006-11-22 国立大学法人 東京大学 有機亜鉛錯体およびその製造方法
TW200637869A (en) * 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
ATE549341T1 (de) 2005-12-23 2012-03-15 Ecobiotics Ltd Spiroketale
WO2007140191A2 (en) 2006-05-23 2007-12-06 Theracos, Inc. Glucose transport inhibitors and methods of use
TWI403516B (zh) 2006-07-27 2013-08-01 Chugai Pharmaceutical Co Ltd To replace spirocyclic alcohol derivatives, and its use as a therapeutic agent for diabetes
JP5791983B2 (ja) 2011-07-07 2015-10-07 三井化学株式会社 樹脂組成物、これを用いたポリイミド金属積層体、及び電子回路用基板

Also Published As

Publication number Publication date
EP2308886A4 (en) 2013-04-03
US8569520B2 (en) 2013-10-29
EP3170834A1 (en) 2017-05-24
US20110306778A1 (en) 2011-12-15
CN102046645A (zh) 2011-05-04
CR20110033A (es) 2011-02-16
WO2009154276A1 (ja) 2009-12-23
JP4823385B2 (ja) 2011-11-24
IL210098A0 (en) 2011-02-28
TW201011043A (en) 2010-03-16
PE20110115A1 (es) 2011-02-14
AR072211A1 (es) 2010-08-11
CA2727923A1 (en) 2009-12-23
JPWO2009154276A1 (ja) 2011-12-01
SG193795A1 (en) 2013-10-30
AU2009261129A1 (en) 2009-12-23
US9163051B2 (en) 2015-10-20
EP3170834B8 (en) 2022-03-23
MX2010014023A (es) 2011-02-15
ZA201100016B (en) 2012-03-28
JP2012001554A (ja) 2012-01-05
EP2308886B1 (en) 2016-12-07
ES2907611T3 (es) 2022-04-25
US20140024817A1 (en) 2014-01-23
KR20110020909A (ko) 2011-03-03
RU2011101972A (ru) 2012-07-27
EP3170834B1 (en) 2022-02-09
MA32530B1 (fr) 2011-08-01
ECSP11010773A (es) 2011-02-28
NZ589961A (en) 2012-12-21
CO6351798A2 (es) 2011-12-20
KR101856784B1 (ko) 2018-05-10
PL3170834T3 (pl) 2022-05-02
CL2010001485A1 (es) 2011-09-16
CN102046645B (zh) 2015-04-01
EP4036100A1 (en) 2022-08-03
EP2308886A1 (en) 2011-04-13
JP5485237B2 (ja) 2014-05-07

Similar Documents

Publication Publication Date Title
ZA201600646B (en) Process for beta-lactone production
EP2291419A4 (en) POLYMACROMONOMER AND PROCESS FOR PRODUCING THE SAME
EP2236540A4 (en) METHOD FOR PRODUCING POLYCARBONATE
HK1161876A1 (zh) α-生育三烯酚及其衍生物的製造方法
EP2303885A4 (en) PROCESS FOR PRODUCING BICYCLOANILINE DERIVATIVES
EP2451259A4 (en) MODULE AND PRODUCTION METHOD THEREOF
EP2271636A4 (en) METHOD FOR PRODUCING DIANEHYDRO SUGAR
HK1160097A1 (zh) 生產氨的方法
EP2129806A4 (en) PROCESS WITH HIGH SCREEN FOR THE PRODUCTION OF DEXTROSE
HK1154589A1 (zh) 螺酮縮醇衍生物的結晶及其製備方法
EP2345624A4 (en) MAYENIC COMPOUND AND MANUFACTURING METHOD THEREFOR
EP2336275A4 (en) PROCESS FOR PRODUCTION OF OLEFINS AND APPARATUS USABLE THEREFOR
EP2133356A4 (en) METHOD FOR PRODUCING A PHOSPHORUS-CONTAINING KETOSIC ACID
EP2292579A4 (en) PROCESS FOR THE PRODUCTION OF HALOGENATED FLUOROETHERS
EP2088136A4 (en) PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
HUE050656T2 (hu) Folyamat a biogáz elõállítására
EP2456778A4 (en) PROCESS FOR PRODUCING FLUOROCYTIDINE DERIVATIVES
EP2213657A4 (en) METHOD AND DEVICE FOR PRODUCING A CYANOHYDRIN COMPOUND AND METHOD FOR PRODUCING AN ALPHA HYDROXYESTER COMPOUND
IL210610A0 (en) Process for producing 6-aryloxyquinoline derivative and intermediate thereof
GB2457820B (en) Production process
IL243809A (en) Process for the production of γ-ketosulfide compounds and γ-ketosulfide compounds obtained
EP2221294A4 (en) PROCESS FOR PREPARING N-CARBAMOYL-TERT.-LEUCIN
HUP0900788A2 (en) Process for producing 4-bromomethyl-biphenyl derivatives
HK1159639A1 (en) Process for the production of organic dithiopyrophosphates
EP2251329A4 (en) PROCESS FOR THE PRODUCTION OF 3-AMINO-2-CHLORO-6-TRIFLUOROMETHYLPYRIDINE